The HIV Point-of-care Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global HIV Point-of-care Testing size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global HIV Point-of-care Testing market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
HIV Point-of-care Testing market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Testing Equipment
Testing Reagent
Market segment by Application can be divided into
Hospitals
Clinics
Home Care Setting
The key market players for global HIV Point-of-care Testing market are listed below:
Abbott
BD
Biomerieux
Adaltis
Roche
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe HIV Point-of-care Testing product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of HIV Point-of-care Testing, with price, sales, revenue and global market share of HIV Point-of-care Testing in 2018 and 2019.
Chapter 3, the HIV Point-of-care Testing competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the HIV Point-of-care Testing breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and HIV Point-of-care Testing market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe HIV Point-of-care Testing sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 HIV Point-of-care Testing Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global HIV Point-of-care Testing Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Testing Equipment
1.2.3 Testing Reagent
1.3 Market Analysis by Application
1.3.1 Overview: Global HIV Point-of-care Testing Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Home Care Setting
1.4 Global HIV Point-of-care Testing Market Size & Forecast
1.4.1 Global HIV Point-of-care Testing Sales in Value (2016-2026))
1.4.2 Global HIV Point-of-care Testing Sales in Volume (2016-2026)
1.4.3 Global HIV Point-of-care Testing Price by Type (2016-2026) & (USD/Unit)
1.5 Global HIV Point-of-care Testing Production Capacity Analysis
1.5.1 Global HIV Point-of-care Testing Total Production Capacity (2016-2026)
1.5.2 Global HIV Point-of-care Testing Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 HIV Point-of-care Testing Market Drivers
1.6.2 HIV Point-of-care Testing Market Restraints
1.6.3 HIV Point-of-care Testing Trends Analysis
2 Manufacturers Profiles
2.1 Abbott
2.1.1 Abbott Details
2.1.2 Abbott Major Business
2.1.3 Abbott HIV Point-of-care Testing Product and Services
2.1.4 Abbott HIV Point-of-care Testing Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 BD
2.2.1 BD Details
2.2.2 BD Major Business
2.2.3 BD HIV Point-of-care Testing Product and Services
2.2.4 BD HIV Point-of-care Testing Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Biomerieux
2.3.1 Biomerieux Details
2.3.2 Biomerieux Major Business
2.3.3 Biomerieux HIV Point-of-care Testing Product and Services
2.3.4 Biomerieux HIV Point-of-care Testing Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Adaltis
2.4.1 Adaltis Details
2.4.2 Adaltis Major Business
2.4.3 Adaltis HIV Point-of-care Testing Product and Services
2.4.4 Adaltis HIV Point-of-care Testing Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Roche
2.5.1 Roche Details
2.5.2 Roche Major Business
2.5.3 Roche HIV Point-of-care Testing Product and Services
2.5.4 Roche HIV Point-of-care Testing Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 HIV Point-of-care Testing Sales by Manufacturer
3.1 Global HIV Point-of-care Testing Sales in Volume by Manufacturer (2019-2021e)
3.2 Global HIV Point-of-care Testing Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in HIV Point-of-care Testing
3.4 Market Concentration Rate
3.4.1 Top 3 HIV Point-of-care Testing Manufacturer Market Share
3.4.2 Top 6 HIV Point-of-care Testing Manufacturer Market Share
3.5 Global HIV Point-of-care Testing Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and HIV Point-of-care Testing Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global HIV Point-of-care Testing Market Size by Region
4.1.1 Global HIV Point-of-care Testing Sales in Volume by Region (2016-2026)
4.1.2 Global HIV Point-of-care Testing Revenue by Region (2016-2026)
4.2 North America HIV Point-of-care Testing Revenue (2016-2026)
4.3 Europe HIV Point-of-care Testing Revenue (2016-2026)
4.4 Asia-Pacific HIV Point-of-care Testing Revenue (2016-2026)
4.5 South America HIV Point-of-care Testing Revenue (2016-2026)
4.6 Middle East and Africa HIV Point-of-care Testing Revenue (2016-2026)
5 Market Segment by Type
5.1 Global HIV Point-of-care Testing Sales in Volume by Type (2016-2026)
5.2 Global HIV Point-of-care Testing Revenue by Type (2016-2026)
5.3 Global HIV Point-of-care Testing Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global HIV Point-of-care Testing Sales in Volume by Application (2016-2026)
6.2 Global HIV Point-of-care Testing Revenue by Application (2016-2026)
6.3 Global HIV Point-of-care Testing Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America HIV Point-of-care Testing Sales by Type (2016-2026)
7.2 North America HIV Point-of-care Testing Sales by Application (2016-2026)
7.3 North America HIV Point-of-care Testing Market Size by Country
7.3.1 North America HIV Point-of-care Testing Sales in Volume by Country (2016-2026)
7.3.2 North America HIV Point-of-care Testing Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe HIV Point-of-care Testing Sales by Type (2016-2026)
8.2 Europe HIV Point-of-care Testing Sales by Application (2016-2026)
8.3 Europe HIV Point-of-care Testing Market Size by Country
8.3.1 Europe HIV Point-of-care Testing Sales in Volume by Country (2016-2026)
8.3.2 Europe HIV Point-of-care Testing Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific HIV Point-of-care Testing Sales by Type (2016-2026)
9.2 Asia-Pacific HIV Point-of-care Testing Sales by Application (2016-2026)
9.3 Asia-Pacific HIV Point-of-care Testing Market Size by Region
9.3.1 Asia-Pacific HIV Point-of-care Testing Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific HIV Point-of-care Testing Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America HIV Point-of-care Testing Sales by Type (2016-2026)
10.2 South America HIV Point-of-care Testing Sales by Application (2016-2026)
10.3 South America HIV Point-of-care Testing Market Size by Country
10.3.1 South America HIV Point-of-care Testing Sales in Volume by Country (2016-2026)
10.3.2 South America HIV Point-of-care Testing Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa HIV Point-of-care Testing Sales by Type (2016-2026)
11.2 Middle East & Africa HIV Point-of-care Testing Sales by Application (2016-2026)
11.3 Middle East & Africa HIV Point-of-care Testing Market Size by Country
11.3.1 Middle East & Africa HIV Point-of-care Testing Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa HIV Point-of-care Testing Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 HIV Point-of-care Testing Typical Distributors
12.3 HIV Point-of-care Testing Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
List of Tables
Table 1. Global HIV Point-of-care Testing Revenue by Type, (USD Million), 2021-2026
Table 2. Global HIV Point-of-care Testing Revenue by Application, (USD Million), 2021-2026
Table 3. Abbott Basic Information, Manufacturing Base and Competitors
Table 4. Abbott Major Business
Table 5. Abbott HIV Point-of-care Testing Product and Services
Table 6. Abbott HIV Point-of-care Testing Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. BD Basic Information, Manufacturing Base and Competitors
Table 8. BD Major Business
Table 9. BD HIV Point-of-care Testing Product and Services
Table 10. BD HIV Point-of-care Testing Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Biomerieux Basic Information, Manufacturing Base and Competitors
Table 12. Biomerieux Major Business
Table 13. Biomerieux HIV Point-of-care Testing Product and Services
Table 14. Biomerieux HIV Point-of-care Testing Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Adaltis Basic Information, Manufacturing Base and Competitors
Table 16. Adaltis Major Business
Table 17. Adaltis HIV Point-of-care Testing Product and Services
Table 18. Adaltis HIV Point-of-care Testing Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Roche Basic Information, Manufacturing Base and Competitors
Table 20. Roche Major Business
Table 21. Roche HIV Point-of-care Testing Product and Services
Table 22. Roche HIV Point-of-care Testing Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Global HIV Point-of-care Testing Sales by Manufacturer (2019-2021e) & (K Units)
Table 24. Global HIV Point-of-care Testing Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 25. Market Position of Manufacturers in HIV Point-of-care Testing, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 26. Global HIV Point-of-care Testing Production Capacity by Company, (K Units): 2020 VS 2021
Table 27. Head Office and HIV Point-of-care Testing Production Site of Key Manufacturer
Table 28. HIV Point-of-care Testing New Entrant and Capacity Expansion Plans
Table 29. HIV Point-of-care Testing Mergers & Acquisitions in the Past Five Years
Table 30. Global HIV Point-of-care Testing Sales by Region (2016-2021e) & (K Units)
Table 31. Global HIV Point-of-care Testing Sales by Region (2021-2026) & (K Units)
Table 32. Global HIV Point-of-care Testing Revenue by Region (2016-2021e) & (USD Million)
Table 33. Global HIV Point-of-care Testing Revenue by Region (2021-2026) & (USD Million)
Table 34. Global HIV Point-of-care Testing Sales by Type (2016-2021e) & (K Units)
Table 35. Global HIV Point-of-care Testing Sales by Type (2021-2026) & (K Units)
Table 36. Global HIV Point-of-care Testing Revenue by Type (2016-2021e) & (USD Million)
Table 37. Global HIV Point-of-care Testing Revenue by Type (2021-2026) & (USD Million)
Table 38. Global HIV Point-of-care Testing Price by Type (2016-2021e) & (USD/Unit)
Table 39. Global HIV Point-of-care Testing Price by Type (2021-2026) & (USD/Unit)
Table 40. Global HIV Point-of-care Testing Sales by Application (2016-2021e) & (K Units)
Table 41. Global HIV Point-of-care Testing Sales by Application (2021-2026) & (K Units)
Table 42. Global HIV Point-of-care Testing Revenue by Application (2016-2021e) & (USD Million)
Table 43. Global HIV Point-of-care Testing Revenue by Application (2021-2026) & (USD Million)
Table 44. Global HIV Point-of-care Testing Price by Application (2016-2021e) & (USD/Unit)
Table 45. Global HIV Point-of-care Testing Price by Application (2021-2026) & (USD/Unit)
Table 46. North America HIV Point-of-care Testing Sales by Country (2016-2021e) & (K Units)
Table 47. North America HIV Point-of-care Testing Sales by Country (2021-2026) & (K Units)
Table 48. North America HIV Point-of-care Testing Revenue by Country (2016-2021e) & (USD Million)
Table 49. North America HIV Point-of-care Testing Revenue by Country (2021-2026) & (USD Million)
Table 50. North America HIV Point-of-care Testing Sales by Type (2016-2021e) & (K Units)
Table 51. North America HIV Point-of-care Testing Sales by Type (2021-2026) & (K Units)
Table 52. North America HIV Point-of-care Testing Sales by Application (2016-2021e) & (K Units)
Table 53. North America HIV Point-of-care Testing Sales by Application (2021-2026) & (K Units)
Table 54. Europe HIV Point-of-care Testing Sales by Country (2016-2021e) & (K Units)
Table 55. Europe HIV Point-of-care Testing Sales by Country (2021-2026) & (K Units)
Table 56. Europe HIV Point-of-care Testing Revenue by Country (2016-2021e) & (USD Million)
Table 57. Europe HIV Point-of-care Testing Revenue by Country (2021-2026) & (USD Million)
Table 58. Europe HIV Point-of-care Testing Sales by Type (2016-2021e) & (K Units)
Table 59. Europe HIV Point-of-care Testing Sales by Type (2021-2026) & (K Units)
Table 60. Europe HIV Point-of-care Testing Sales by Application (2016-2021e) & (K Units)
Table 61. Europe HIV Point-of-care Testing Sales by Application (2021-2026) & (K Units)
Table 62. Asia-Pacific HIV Point-of-care Testing Sales by Region (2016-2021e) & (K Units)
Table 63. Asia-Pacific HIV Point-of-care Testing Sales by Region (2021-2026) & (K Units)
Table 64. Asia-Pacific HIV Point-of-care Testing Revenue by Region (2016-2021e) & (USD Million)
Table 65. Asia-Pacific HIV Point-of-care Testing Revenue by Region (2021-2026) & (USD Million)
Table 66. Asia-Pacific HIV Point-of-care Testing Sales by Type (2016-2021e) & (K Units)
Table 67. Asia-Pacific HIV Point-of-care Testing Sales by Type (2021-2026) & (K Units)
Table 68. Asia-Pacific HIV Point-of-care Testing Sales by Application (2016-2021e) & (K Units)
Table 69. Asia-Pacific HIV Point-of-care Testing Sales by Application (2021-2026) & (K Units)
Table 70. South America HIV Point-of-care Testing Sales by Country (2016-2021e) & (K Units)
Table 71. South America HIV Point-of-care Testing Sales by Country (2021-2026) & (K Units)
Table 72. South America HIV Point-of-care Testing Revenue by Country (2016-2021e) & (USD Million)
Table 73. South America HIV Point-of-care Testing Revenue by Country (2021-2026) & (USD Million)
Table 74. South America HIV Point-of-care Testing Sales by Type (2016-2021e) & (K Units)
Table 75. South America HIV Point-of-care Testing Sales by Type (2021-2026) & (K Units)
Table 76. South America HIV Point-of-care Testing Sales by Application (2016-2021e) & (K Units)
Table 77. South America HIV Point-of-care Testing Sales by Application (2021-2026) & (K Units)
Table 78. Middle East & Africa HIV Point-of-care Testing Sales by Country (2016-2021e) & (K Units)
Table 79. Middle East & Africa HIV Point-of-care Testing Sales by Country (2021-2026) & (K Units)
Table 80. Middle East & Africa HIV Point-of-care Testing Revenue by Country (2016-2021e) & (USD Million)
Table 81. Middle East & Africa HIV Point-of-care Testing Revenue by Country (2021-2026) & (USD Million)
Table 82. Middle East & Africa HIV Point-of-care Testing Sales by Type (2016-2021e) & (K Units)
Table 83. Middle East & Africa HIV Point-of-care Testing Sales by Type (2021-2026) & (K Units)
Table 84. Middle East & Africa HIV Point-of-care Testing Sales by Application (2016-2021e) & (K Units)
Table 85. Middle East & Africa HIV Point-of-care Testing Sales by Application (2021-2026) & (K Units)
Table 86. Direct Channel Pros & Cons
Table 87. Indirect Channel Pros & Cons
Table 88. HIV Point-of-care Testing Typical Distributors
Table 89. HIV Point-of-care Testing Typical Customers
List of Figures
Figure 1. HIV Point-of-care Testing Picture
Figure 2. Global HIV Point-of-care Testing Sales Market Share by Type in 2020
Figure 3. Testing Equipment
Figure 4. Testing Reagent
Figure 5. Global HIV Point-of-care Testing Sales Market Share by Application in 2020
Figure 6. Hospitals
Figure 7. Clinics
Figure 8. Home Care Setting
Figure 9. Global HIV Point-of-care Testing Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 10. Global HIV Point-of-care Testing Market Size and Forecast (2016-2026) & (USD Million)
Figure 11. Global HIV Point-of-care Testing Sales (2016-2026) & (K Units)
Figure 12. Global HIV Point-of-care Testing Price by Type (2016-2026) & (USD/Unit)
Figure 13. Global HIV Point-of-care Testing Production Capacity (2016-2026) & (K Units)
Figure 14. Global HIV Point-of-care Testing Production Capacity by Geographic Region: 2020 VS 2021
Figure 15. HIV Point-of-care Testing Market Drivers
Figure 16. HIV Point-of-care Testing Market Restraints
Figure 17. HIV Point-of-care Testing Market Trends
Figure 18. Global HIV Point-of-care Testing Sales Market Share by Manufacturer in 2020
Figure 19. Global HIV Point-of-care Testing Revenue Market Share by Manufacturer in 2020
Figure 20. HIV Point-of-care Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 21. Top 3 HIV Point-of-care Testing Manufacturer (Revenue) Market Share in 2020
Figure 22. Top 6 HIV Point-of-care Testing Manufacturer (Revenue) Market Share in 2020
Figure 23. Global HIV Point-of-care Testing Sales Market Share by Region (2016-2026)
Figure 24. Global HIV Point-of-care Testing Revenue Market Share by Region (2016-2026)
Figure 25. North America HIV Point-of-care Testing Revenue (2016-2026) & (USD Million)
Figure 26. Europe HIV Point-of-care Testing Revenue (2016-2026) & (USD Million)
Figure 27. Asia-Pacific HIV Point-of-care Testing Revenue (2016-2026) & (USD Million)
Figure 28. South America HIV Point-of-care Testing Revenue (2016-2026) & (USD Million)
Figure 29. Middle East & Africa HIV Point-of-care Testing Revenue (2016-2026) & (USD Million)
Figure 30. Global HIV Point-of-care Testing Sales Market Share by Type (2016-2026)
Figure 31. Global HIV Point-of-care Testing Revenue Market Share by Type (2016-2026)
Figure 32. Global HIV Point-of-care Testing Price by Type (2016-2026) & (USD/Unit)
Figure 33. Global HIV Point-of-care Testing Sales Market Share by Application (2016-2026)
Figure 34. Global HIV Point-of-care Testing Revenue Market Share by Application (2016-2026)
Figure 35. Global HIV Point-of-care Testing Price by Application (2016-2026) & (USD/Unit)
Figure 36. North America HIV Point-of-care Testing Sales Market Share by Type (2016-2026)
Figure 37. North America HIV Point-of-care Testing Sales Market Share by Application (2016-2026)
Figure 38. North America HIV Point-of-care Testing Sales Market Share by Country (2016-2026)
Figure 39. North America HIV Point-of-care Testing Revenue Market Share by Country (2016-2026)
Figure 40. United States HIV Point-of-care Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 41. Canada HIV Point-of-care Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Mexico HIV Point-of-care Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Europe HIV Point-of-care Testing Sales Market Share by Type (2016-2026)
Figure 44. Europe HIV Point-of-care Testing Sales Market Share by Application (2016-2026)
Figure 45. Europe HIV Point-of-care Testing Sales Market Share by Country (2016-2026)
Figure 46. Europe HIV Point-of-care Testing Revenue Market Share by Country (2016-2026)
Figure 47. Germany HIV Point-of-care Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. France HIV Point-of-care Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. United Kingdom HIV Point-of-care Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Russia HIV Point-of-care Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Italy HIV Point-of-care Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Asia-Pacific HIV Point-of-care Testing Sales Market Share by Region (2016-2026)
Figure 53. Asia-Pacific HIV Point-of-care Testing Sales Market Share by Application (2016-2026)
Figure 54. Asia-Pacific HIV Point-of-care Testing Sales Market Share by Region (2016-2026)
Figure 55. Asia-Pacific HIV Point-of-care Testing Revenue Market Share by Region (2016-2026)
Figure 56. China HIV Point-of-care Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Japan HIV Point-of-care Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Korea HIV Point-of-care Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. India HIV Point-of-care Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Southeast Asia HIV Point-of-care Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Australia HIV Point-of-care Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. South America HIV Point-of-care Testing Sales Market Share by Type (2016-2026)
Figure 63. South America HIV Point-of-care Testing Sales Market Share by Application (2016-2026)
Figure 64. South America HIV Point-of-care Testing Sales Market Share by Country (2016-2026)
Figure 65. South America HIV Point-of-care Testing Revenue Market Share by Country (2016-2026)
Figure 66. Brazil HIV Point-of-care Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Argentina HIV Point-of-care Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Middle East & Africa HIV Point-of-care Testing Sales Market Share by Type (2016-2026)
Figure 69. Middle East & Africa HIV Point-of-care Testing Sales Market Share by Application (2016-2026)
Figure 70. Middle East & Africa HIV Point-of-care Testing Sales Market Share by Country (2016-2026)
Figure 71. Middle East & Africa HIV Point-of-care Testing Revenue Market Share by Country (2016-2026)
Figure 72. Turkey HIV Point-of-care Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Egypt HIV Point-of-care Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Saudi Arabia HIV Point-of-care Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. South Africa HIV Point-of-care Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
Figure 77. Methodology
Figure 78. Research Process and Data Source